- Home
- Publications
- Publication Search
- Publication Details
Title
The use of viral vectors in vaccine development
Authors
Keywords
-
Journal
npj Vaccines
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-04
DOI
10.1038/s41541-022-00503-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
- (2021) Isaac See et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults
- (2021) Glenda E. Gray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
- (2021) Wei Zhan et al. Frontiers in Immunology
- Ebola virus requires phosphatidylserine scrambling activity for efficient budding and optimal infectivity
- (2021) Marissa D. Acciani et al. JOURNAL OF VIROLOGY
- Elevated HIV Infection of CD4 T Cells in MRKAd5 Vaccine Recipients Due to CD8 T Cells Targeting Adapted Epitopes
- (2021) Kai Qin et al. JOURNAL OF VIROLOGY
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- A ‘mix and match’ approach to SARS-CoV-2 vaccination
- (2021) Meagan E. Deming et al. NATURE MEDICINE
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
- (2021) Tina Schmidt et al. NATURE MEDICINE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
- (2021) Ahmed O. Hassan et al. Cell Reports
- Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
- (2021) Guodong Liu et al. Pathogens
- Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
- (2021) Andreas Greinacher et al. BLOOD
- ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome
- (2021) Alexander T. Baker et al. Science Advances
- Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
- (2020) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR
- (2020) Jasmina Cehajic-Kapetanovic et al. NATURE MEDICINE
- Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
- (2020) Fatima Laher et al. PLOS MEDICINE
- Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
- (2020) Punnee Pitisuttithum et al. Lancet HIV
- A Vaccine against Ebola Virus
- (2020) Erica Ollmann Saphire CELL
- A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus
- (2020) Min Wen Ku et al. MOLECULAR THERAPY
- T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers
- (2020) Prabhu S. Arunachalam et al. NATURE MEDICINE
- Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
- (2020) Maria Blasi et al. npj Vaccines
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
- (2020) Alessandra Gallinaro et al. Molecular Therapy-Methods & Clinical Development
- Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity
- (2020) Yi-Yu Lin et al. Molecular Therapy-Methods & Clinical Development
- Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach
- (2020) Huiren Zhao et al. Molecular Therapy-Methods & Clinical Development
- Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
- (2020) Min-Wen Ku et al. Cell Host & Microbe
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor
- (2020) Alicia D. Powers et al. Molecular Therapy-Methods & Clinical Development
- Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
- (2020) Maria Blasi et al. npj Vaccines
- Insect-specific virus evolution and potential effects on vector competence
- (2019) Pontus Öhlund et al. VIRUS GENES
- Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
- (2019) José M. Martinez-Navio et al. IMMUNITY
- Production of adeno-associated virus vectors for in vitro and in vivo applications
- (2019) Toyokazu Kimura et al. Scientific Reports
- Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
- (2019) Giuseppe Pantaleo et al. Lancet HIV
- A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
- (2019) Jody Hobson-Peters et al. Science Translational Medicine
- Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience
- (2018) Ioannis S. Dimopoulos et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
- (2018) Lindsey R Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- A VSV-based Zika virus vaccine protects mice from lethal challenge
- (2018) Jackson Emanuel et al. Scientific Reports
- The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
- (2018) Ellen Suder et al. Human Vaccines & Immunotherapeutics
- Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
- (2018) Alessandra Gallinaro et al. Frontiers in Immunology
- Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
- (2018) Navin Venkatraman et al. JOURNAL OF INFECTIOUS DISEASES
- First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1
- (2018) Kathryn E. Stephenson et al. PLoS One
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Jing-Xin Li et al. Lancet Global Health
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques
- (2016) Donatella Negri et al. MOLECULAR THERAPY
- A chikungunya fever vaccine utilizing an insect-specific virus platform
- (2016) Jesse H Erasmus et al. NATURE MEDICINE
- Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies
- (2016) Surender Khurana et al. NATURE MEDICINE
- Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials
- (2015) Héla Kallel et al. Biotechnology Journal
- Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model
- (2015) Kristy Offerman et al. BMC GENOMICS
- Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials
- (2015) Héla Kallel et al. Biotechnology Journal
- Pre-existing immunity against Ad vectors
- (2014) Hugues Fausther-Bovendo et al. Human Vaccines & Immunotherapeutics
- AAV Vectors Vaccines Against Infectious Diseases
- (2014) Karen Nieto et al. Frontiers in Immunology
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Protection Against Henipavirus Infection by Use of Recombinant Adeno-Associated Virus–Vector Vaccines
- (2012) Aurélie Ploquin, Judit Szécsi, Cyrille Mathieu, Vanessa Guillaume, Véronique Barateau, Kien Chai Ong et al. JOURNAL OF INFECTIOUS DISEASES
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria
- (2012) Frédéric Coutant et al. PLoS One
- An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1–infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)
- (2011) D. W. Fitzgerald et al. JOURNAL OF INFECTIOUS DISEASES
- The STEP Study Provides a Hint That Vaccine Induction of the Right CD8+ T Cell Responses Can Facilitate Immune Control of HIV
- (2011) M. Altfeld et al. JOURNAL OF INFECTIOUS DISEASES
- Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection
- (2011) R. R. Bradley et al. JOURNAL OF VIROLOGY
- Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors
- (2011) Esther D. Quakkelaar et al. PLoS One
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
- (2011) Dan H. Barouch et al. VACCINE
- Production of adenovirus vectors and their use as a delivery system for influenza vaccines
- (2010) Sai V Vemula et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Current Good Manufacturing Practice Production of an Oncolytic Recombinant Vesicular Stomatitis Viral Vector for Cancer Treatment
- (2010) L.J. Ausubel et al. HUMAN GENE THERAPY
- Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
- (2010) Glenda Gray et al. Current Opinion in HIV and AIDS
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells
- (2009) Natalie A Hutnick et al. NATURE MEDICINE
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now